ElsaLys Biotech — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
newsalert

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Design of an anti-CD160 mAb targeting CLL, HCL and immune cells for leukemia immunotherapy

Home
Explore Partnerships
Partnerships
Eurostars 2
Eurostars Cut-Off 6
Design of an anti-CD160 mAb targeting CLL, HCL and immune cells for leukemia immunotherapy
ElsaLys Biotech

Full name	ElsaLys Biotech
Short name	ELB
Type of organisation	Private - SME
Partner Role	Coordinator
Country	France

Back to project overview

Funded by the European Union under the Grant Agreement no. 101102316. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on LinkedIn

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.